The authoritative source for research information and outputs is Elsevier Scopus, with researcher profile verification from the Deanship of Scientific Research.
المخرجات
Research outputs
Articles, reviews, conference papers and book chapters, indexed by DOI and linked to University researchers.
Fractional carbon dioxide (FCO₂) laser-assisted topical therapy has been investigated to enhance drug delivery in nail psoriasis, but improvement from baseline does not establish whether laser pretreatment provides additional clinical benefit.This systematic review evaluated the comparative efficacy, safety, tolerability, and durability of FCO₂-assisted topical therapy.PubMed/MEDLINE, Scopus, and Web of Science were searched from inception through September 18, 2026.Comparative controlled studies were eligible, and risk of bias was assessed using the Cochrane RoB 2 tool.Five studies involving 134 participants were included.Three compared FCO₂-assisted topical therapy with the same topical agent alone, one compared two FCO₂-assisted topical regimens, and one compared laser-assisted topical corticosteroid therapy with intralesional corticosteroid treatment.Although nail severity improved over time across studies, direct comparative effects were inconsistent and varied by topical agent, comparator, and assessment time.Between-treatment advantages were observed in selected tazarotene and methotrexate comparisons, whereas other comparisons showed no clear incremental benefit.Laser-assisted corticosteroid treatment achieved broadly comparable short-term outcomes to intralesional therapy with less procedural pain and greater patient satisfaction.Four of five principal efficacy results were at high risk of bias, and one raised some concerns.Meta-analysis was not appropriate because of substantial heterogeneity.Current evidence does not establish a consistent incremental efficacy advantage of laser assistance.More rigorous, adequately powered trials with appropriate paired analyses and standardized follow-up are needed before routine adjunctive use can be recommended.
nail psoriasisfractional CO2 lasertopical treatmentclinical outcomes
Journal of Family Medicine and Primary Care · vol. 15 (8) · 3043-3047
A BSTRACT Introduction: Atopic dermatitis (AD) is a chronic, relapsing inflammatory skin disease affecting 2.1–4.9% of adults worldwide. It commonly coexists with asthma, allergic rhinitis, and food allergies, and is influenced by genetic and environmental factors. Objective: To evaluate the impact of atopic dermatitis on quality of life among adults. Methods: A cross-sectional study was conducted among adults (≥18 years) with atopic dermatitis attending dermatology clinics between July and September 2025. Participants with active skin infections were excluded. Results: Among 600 participants, misconceptions were common: (24.9%) believed treatment could cure AD, and 24% viewed topical corticosteroids as unsafe. Frequent comorbidities included asthma (57%), allergic rhinitis (55%), and parental history (59.5%). Psychosocial effects were notable, with over half reporting impaired daily activities and relationships. Limitations: The study was conducted in a single geographical setting and included patients attending dermatology clinics, which may limit the generalizability of the findings to the broader population. A relatively short data collection period may have limited the ability to detect less frequent associations or seasonal variations in disease severity. Conclusion: Substantial knowledge gaps and psychosocial impact emphasize the need for enhanced patient education, improved patient–physician communication, and comprehensive management strategies to optimize outcomes and quality of life in adults with atopic dermatitis.
atopic dermatitisquality of lifeadultspsychosocial impact
Nail lichen planus (NLP) is a chronic immune-mediated inflammatory disorder and one of the most challenging forms of lichen planus to treat. Conventional therapies, including intralesional corticosteroids, systemic immunosuppressants, and topical agents, are often associated with high failure rates and significant adverse effects. Janus kinase inhibitors (JAKIs) have emerged as mechanistically rational therapeutic agents because of the central role of the interferon (IFN)-JAK-signal transducer and activator of transcription (JAK-STAT) pathway in lichenoid inflammation; however, their efficacy and safety in NLP have not yet been systematically evaluated. A systematic review was conducted by searching PubMed, Scopus, and Web of Science from database inception through March 2026 in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines. Eligible studies included patients with clinically and/or histopathologically confirmed NLP and studies reporting original patient-level data of any design. Risk of bias was assessed using the Joanna Briggs Institute (JBI) critical appraisal tools appropriate to each study design. A cumulative time-to-response model was constructed, and a random-effects meta-analysis of standardized mean change (SMC) in nail severity scores was performed where data permitted. Thirteen studies were included with a total of 25 patients. Interventions included oral and topical tofacitinib, baricitinib, abrocitinib, upadacitinib, and topical ruxolitinib. Clinically meaningful improvement was reported across all studies, with most responses occurring within three to seven months of treatment initiation. The pooled SMC was 1.65 (95% confidence interval (CI): 0-3.59), with substantial heterogeneity (I²=87.6%). No serious adverse events were reported. Overall, JAKIs appear to be effective and well tolerated in the short term for refractory NLP, supporting their potential role as rescue therapy in selected cases. However, the current evidence remains limited and heterogeneous, underscoring the need for prospective randomized controlled trials with standardized outcome measures and longer follow-up durations.
nail lichen planusJAK inhibitorsrefractory lichen planustofacitinib
Purpose Graves’ ophthalmopathy (GO) is an autoimmune orbital inflammatory disease associated with Graves’ disease. It can cause vision loss, facial disfigurement, and reduced quality of life. Systemic corticosteroids remain the first-line treatment for moderate-to-severe GO, administered either orally or intravenously. However, the optimal route of administration remains uncertain, with ongoing debate regarding their comparative efficacy and safety.The aim of this review is to compare the efficacy and safety of intravenous versus oral corticosteroids in the treatment of moderate-to-severe GO.Methods Randomized controlled trials were included. Risk of bias was assessed using the Cochrane RoB 2 tool. Outcomes focused on efficacy and safety of intravenous versus oral glucocorticoids in the treatment of GO.Results Five eligible RCTs involving 288 patients were analyzed. Intravenous steroids appeared to improve the clinical activity score (MD = −0.57; 95% CI: −0.82 to −0.33; p < 0.00001) and reduce the risk of Cushingoid facial features (RR = 0.17; 95% CI: 0.08 to 0.35; p < 0.00001). However, limited efficacy was observed in diplopia, proptosis, and in minimizing other steroid-related adverse events.Conclusion IV steroids were associated with more favourable outcomes and better tolerability than oral steroids in moderate-to-severe GO. Further comprehensive trials are needed to confirm long-term safety and optimize treatment protocols.
Objective: The purpose of this study was to evaluate the efficacy of combination therapy with oral acyclovir and antifungal drugs in addressing persistent dermatophytosis, particularly in patients with viral co-infections and impaired immune systems. Methods: A prospective study was performed on eight patients with persistent fungal infections who were all treated with a combination of antifungal drugs, oral acyclovir, topical steroids, antihistamines, and supportive care. Patient outcomes were monitored over six months. Recovery time and the efficacy of preventive courses were assessed. Results: All patients were fully recovered within six months. Symptoms subsided within 2-4 weeks, and full recovery occurred in 6-8 weeks. Preventive courses helped to avoid relapses. Combining antiviral and antifungal drugs proved valuable, especially in cases of treatment resistance or recurring infections. Conclusion: The study focuses on the potential benefits of combining oral acyclovir with antifungal medications for treating recalcitrant dermatophytosis. This method is a promising strategy for improving outcomes in difficult cases, particularly for patients with viral co-infections. Further research with controlled studies is necessary to confirm these findings.
OBJECTIVE: This study aimed to evaluate the efficacy of platelet-rich plasma (PRP) injections in managing lateral epicondylitis (LE), focusing on pain relief, functional improvement, side effects, and patient satisfaction. METHODS: A retrospective analysis of 19 patients treated with PRP injections at a tertiary care center was conducted. Data included demographic characteristics, Visual Analog Scale (VAS) pain scores, Disabilities of the Arm, Shoulder, and Hand (DASH) scores, and patient satisfaction. Statistical analyses utilized paired t-tests and one-sample proportion tests. Statistical significance was set at p<0.05. RESULTS: PRP injections significantly reduced VAS pain scores, with 21.05% (4/19) of patients achieving complete pain relief (VAS=0) and 47.37% (9/19) reducing scores to ≤3 (p=0.027). DASH scores improved substantially, with mean scores decreasing from 87.5% (19/19) (95% CI: 82.3-92.7%) pre-treatment to 18.5% (19/19) (95% CI: 12.7-24.3%) post-treatment (p<0.001). Prior corticosteroid use was associated with poorer outcomes (p=0.012). Patient satisfaction was high, with 89.5% (16/19) of patients reporting being "very satisfied" or "satisfied" (p=0.001). CONCLUSION: PRP injections offer significant pain relief and functional improvement for patients with LE. This minimally invasive treatment is particularly valuable for high-demand populations, such as professional athletes, due to faster recovery times and reduced need for surgery. However, high patient satisfaction rates underscore its clinical utility. Prospective studies with larger cohorts are needed to further validate these findings and refine PRP protocols.
Objective This study evaluated the impact of adenotonsillectomy on asthma symptoms in children by combining observational evidence with pooled analysis.Data sources We searched MEDLINE/PubMed, Cochrane Central Register of Controlled Trials, Web of Science, ProQuest, and Scopus from inception to March 17, 2025.Study selection Eligible studies assessed asthma outcomes in children undergoing adenotonsillectomy using retrospective or prospective cohort designs, case series, or database analyses. Eleven studies involving 74,204 participants were identified. Outcomes included asthma control scores (ACT/cACT), acute asthma exacerbations (AAEs), emergency department (ED) visits, oral corticosteroid use, hospitalization, inflammatory biomarkers, and atopic risk. Risk of bias was evaluated using ROBINS-I.Results Meta-analysis incorporated five studies with 52,479 participants. Adenotonsillectomy improved ACT/cACT scores by a mean of 2.5 points (95% CI:1.6–3.4; I2=0%), indicating better asthma control. A reduced risk of AAEs was observed (RD = 0.29; 95% CI:0.01–0.58), though with extreme heterogeneity (I2=100%). ED visits showed a small but significant reduction (MD=–0.01; 95% CI:0.00–0.02; I2=0%). Narrative synthesis found corticosteroid courses decreased by 23.7%, hospitalization rates fell by up to 35.8%, and patients reported improved quality of life and lower inflammatory biomarkers. However, most studies carried moderate to severe risk of bias due to confounding and selection issues.Conclusions Adenotonsillectomy may improve asthma control, reduce ED visits, and lessen medication use and hospitalization among children. Evidence regarding its effect on exacerbations remains inconsistent, and causality cannot be inferred due to reliance on observational data. Well-designed prospective controlled trials are needed to confirm effectiveness and clarify underlying mechanisms.
A particular type of dermatosis known as prurigo of pregnancy (PP) is typified by highly itchy papulonodules that primarily affect the extremities' extensor surfaces and the hand and feet dorsum. Despite PP not being a rare illness, there is surprisingly a distinct lack of studies exploring its depth. Therefore, this study seeks to thoroughly describe the clinical manifestation and treatment of pregnancy-related prurigo. Additionally, it aims to provide a comprehensive and up-to-date assessment of the effectiveness of different approaches to pregnancy prurigo therapy. This systematic review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The systematic review searched PubMed, EMBASE, Web of Science, and Cochrane databases from the databases' establishment to 13 August 2024. The studies were deemed included if they were randomized controlled trials (RCTs), cohort studies, case-control, cross-sectional, case series, and case reports; if they reported clinical manifestations and treatment for PP; and if they were written in the English language. Studies were excluded if they did not meet the aforementioned inclusion criteria; moreover, they were excluded if they were of high risk of bias or low quality. The articles included were assessed using the Newcastle-Ottawa scale and methodological quality, and the synthesis of non-randomized studies. Four different studies, with a total of 63 patients, were included in our article. The typical rash of PP is described in most patients with variable onset and distribution on the body, from the extremities to the back to the buttocks. PP can be associated with a variety of conditions, including a history of other skin conditions, such as intrahepatic cholestasis and other medical conditions. Different treatments for PP in pregnant women were reported across the included studies, most commonly a combination of topical steroids, emollients, oral antihistamines, oral corticosteroids, and ultraviolet narrow band (UVB). The effectiveness of the various therapies is variable; some patients recover before delivery, while others recover months postpartum. This systematic review emphasizes how complicated PP is in terms of both its clinical manifestations, associations, and management. The evidence points to the urgent need for a more uniform approach to diagnosis and management due to substantial variability in the clinical features, onset, and treatment responses. The study emphasizes the need for additional, larger-scale research using standardized outcome measures to identify characteristics that predict treatment success and allow for more robust comparisons of treatment modalities.
prurigo of pregnancyprurigo nodularisprurituspregnancy
BACKGROUND: In order to enhance patient outcomes, Sudden Sensorineural Hearing Loss (SSNHL) must be diagnosed and treated quickly. In the early detection and treatment of SSNHL, primary care physicians (PCPs) are essential. The purpose of this study was to assess Saudi Arabian primary healthcare physicians diagnostic abilities, knowledge and practices related to SSNHL. METHODS: A cross-sectional survey of 371 PCPs in Saudi Arabia was carried out. An electronic questionnaire measuring participants knowledge, diagnosis and management methods, referral practices of SSNHL was used to gather data. SPSS version 26 was used for the statistical analysis, and a p-value of <0.05 was considered significant. RESULTS: 124 (33.4%) of participants showed good knowledge, 123 (33.2%) fair knowledge, and 124 (33.4%) poor knowledge, with a mean knowledge score of 10.58±3.85. Most physicians 282 (76%) attempted to differentiate between sensorineural and conductive hearing loss, primarily using tuning fork tests 261 (70.4%) and audiological evaluations 258 (69%). While 327 (88.1%) recognized SSNHL as requiring urgent referral for audiological testing, only 184 (49.6%) could accurately define the condition within the critical 72-hour window. Corticosteroids were prescribed by 138 (37.2%) for suspected SSNHL and 185 (49.9%) for confirmed cases. Good knowledge was significantly associated with fewer years of practice, urban-based patient care, and walk-in clinic settings (p<0.05). CONCLUSION: Although the majority of Saudi Arabian PCPs agree that SSNHL is urgent, there are still gaps in their understanding and adherence to evidence-based practices. To increase diagnostic accuracy, timely referrals, and the effective management of SSNHL cases, more training and education are advised.
sudden sensorineural hearing lossprimary care physiciansphysician knowledgediagnostic accuracy
Advanced Health Science and Technology Journal · vol. 1 (2) · 86-91
Abstract Background: Chronic rhinosinusitis (CRS) is a persistent inflammatory disorder of the paranasal sinuses, significantly impairing quality of life (QoL). While corticosteroids are central to CRS management, evidence from Saudi Arabia remains limited. Objectives: This study aimed to (1) evaluate the improvement in CRS symptoms following corticosteroid therapy, (2) compare the effectiveness of intranasal versus systemic corticosteroids, (3) analyze side effects, and (4) assess the impact of therapy on QoL among Saudi patients. Methodology: A cross-sectional descriptive study was conducted among Saudi adults with physician-diagnosed CRS and prior corticosteroid use. Data were collected via an online questionnaire incorporating the validated Sino-Nasal Outcome Test-22. Descriptive and inferential statistics were performed using SPSS. Results: Of 201 participants, 78.6% had a CRS diagnosis and 70.6% used intranasal corticosteroids. Most patients (88.6%) reported moderate-to-complete improvement in symptoms, with intranasal sprays demonstrating significantly greater effectiveness compared to oral corticosteroids ( P < 0.001). Adverse effects were rare, with 95.5% reporting none; headaches (2.5%) and nausea (1.0%) were the most common. Quality-of-life scores improved, although persistent issues included nasal congestion, loss of smell, and daily irritation. Conclusion: Corticosteroid therapy–particularly intranasal sprays–is highly effective and well-tolerated in Saudi patients with CRS. These findings align with global evidence and highlight the need for patient education and improved adherence to optimize outcomes within the Saudi healthcare context.
Acute generalized exanthematous pustulosis (AGEP) is a rare pustular eruption commonly triggered by drugs. It is characterized by acute onset of pustules on erythematous-edematous skin and often presents with fever. This report describes AGEP following exposure to iodinated contrast media (ICM), specifically iobitridol, in a 68-year-old male with multiple comorbidities. The patient developed characteristic erythematous patches with pustules on the body after initial CT imaging with ICM for a prostate abscess. Histological findings and recurrence following re-exposure confirmed AGEP, which was attributed to ICM. This case emphasizes the need for awareness of ICM as a potential trigger for AGEP. Management included topical steroids and antihistamines, resulting in a rapid recovery.
acute generalized exanthematous pustulosisiodinated contrast mediaiobitridolcontrast media hypersensitivity
) bacteria, causing inflammation, and the formation of pimples or lesions. Acne was recognized in the ancient times by the ancient Egyptians, Greeks, and Romans. Since ancient times, folk medicine from different cultures have comprised herbal and natural products for the treatment of acne. Current acne medications include antibiotics, keratolytics, corticosteroids, in addition to hormonal therapy for women. However, these conventional drugs can cause some serious side effects. And therefore, seeking new safe treatment options from natural sources is essential. Plants can be a potential source of medicinal phytochemicals which can be pharmacologically active as antibacterial, antioxidant, anti-inflammatory, keratolytic and sebum-reducing. Organic acids, obtained from natural sources, are commonly used as keratolytics in dermatology and cosmetology. Most of the promising phytochemicals in acne treatment belong to terpenes, terpenoids, flavonoids, alkaloids, phenolic compounds, saponins, tannins, and essential oils. These can be extracted from leaves, bark, roots, rhizomes, seeds, and fruits of plants and may be incorporated in different dosage forms to facilitate their penetration through the skin. Additionally, medicinal compounds from marine sources can also contribute to acne treatment. This review will discuss the pathogenesis, types and consequences of acne, side effects of conventional treatment, current possible treatment options from natural sources obtained from research and folk medicine and possible applied dosage forms.
Journal of Neurosurgery Spine · vol. 40 (5) · 653-661
OBJECTIVE: The objective was to evaluate the efficacy, outcomes, and complications of surgical intervention performed within 24 hours (≤ 24 hours) versus after 24 hours (> 24 hours) in managing acute traumatic central cord syndrome (ATCCS). METHODS: Articles pertinent to the study were retrieved from PubMed, Scopus, Web of Science, and Cochrane. The authors performed a systematic review and meta-analysis of treatment procedures and outcomes according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRIMSA) guidelines. RESULTS: Seven articles comprising 488 patients were included, with 188 (38.5%) patients in the ≤ 24-hour group and 300 (61.5%) in the > 24-hour group. Significant differences were not found between groups in terms of demographic characteristics, injury mechanism, spinal cord compression level, neuroimaging features, and the American Spinal Injury Association (ASIA) motor score at admission. Both groups had a similar approach to surgery and steroid administration. The surgical complication rate was significantly higher in the > 24-hour group (4.5%) compared to the ≤ 24-hour group (1.2%) (p = 0.05). Clinical follow-up duration was similar at 12 months (interquartile range 3-36) for both groups (p > 0.99). The ≤ 24-hour group demonstrated a not statistically significant greater improvement in ASIA motor score, with a mean difference of 12 (95% CI -20.7 to 44.6) compared to the > 24-hour group. CONCLUSIONS: The present study indicates potential advantages of early (≤ 24 hours) surgery in ATCCS patients, specifically in terms of lower complication rates. However, further research is needed to confirm these findings and their clinical implications.
spinal cord injurytiming of surgeryearly surgical interventiondelayed surgery
Journal of Family Medicine and Primary Care · vol. 13 (11) · 5067-5071
Background: Bell's palsy (BP) is a cranial nerve disorder in which unilateral or bilateral paralysis of the facial nerve occurs. The study aims to study BP's characteristics, including its clinical manifestations, prognosis, and complications among adult patients aged 18 years and above. Methods: A retrospective study of adult patients diagnosed with BP in a primary care setting] [January 2015 to December 2022]. Results: The study included a total number of 92 patients with an incidence rate of 23 cases per 100,000 people. The mean age was 43.52 years. The most common symptoms reported were dropping of the mouth at 38.9%, loss of forehead muscle movement at 24.4%, loss of nasolabial fold at 22.2%, loss of facial expressions at 20%, and headache at 18.9%. Immunodeficiency affected 2.3% of the patients. The management of patients involved the use of steroids in 76.1% and the use of antiretroviral medications in 48.9%. Physiotherapy was used in 29.5%. The complete recovery rate during the first year was 90.8%. The rate of complete recovery within two years was 96.9%. Conclusion: The incidence of BP in the region seems to be similar to the incidence rate reported elsewhere in the world. The use of antiviral therapy seems to be high despite the controversy around the use of antivirals in the management of BP. The majority of patients with BP recover within the first year.
Background The use of topical steroids for skin whitening is prevalent in many regions, including Saudi Arabia. This study aims to analyze the patterns, motivations, and demographic factors associated with the use of topical steroids for cosmetic purposes in Jazan, Saudi Arabia. Methods This cross-sectional survey was conducted online over three weeks. A structured questionnaire was distributed to adults residing in Jazan, collecting data on demographics, topical steroid use, motivations, and product sources. Descriptive statistics were used to analyze the data. Results Among the 340 participants, 173 (50.9%) reported using topical steroids for skin whitening. The majority of users were female (149, 43.8%) and aged between 20 and 30 years (78, 22.9%). Most participants had used topical steroids for less than a year (127, 73.4%), with usage predominantly in the evening (86, 49.7%). Topical steroids were primarily purchased from pharmacies (70, 40.5%), with significant monthly expenditure variability: 55 participants (31.8%) spent between 50 and 110 SAR, and 62 (35.7%) spent more than 150 SAR. Motivations for use included a preference for lighter skin (49, 28.4%) and treatment of melasma (42, 24.3%). Recommendations from friends (71, 41.0%) and TV advertisements (34, 19.8%) influenced product choice. Conclusion Topical steroid use for skin whitening is widespread among adults in Jazan, with a notable emphasis on cosmetic outcomes and substantial financial investment. There is a critical need for increased public education on the risks associated with topical steroids and enhanced professional guidance to promote safer usage practices.
topical corticosteroidsskin lighteningcauses of drug usemelasma